Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide
Citations Over TimeTop 10% of 2015 papers
Abstract
Tamoxifen is a selective oestrogen receptor modulator widely used for the treatment of breast cancer. In addition to its activity as an oestrogen receptor agonist/antagonist, tamoxifen also modulates sphingolipid biosynthesis, which has been shown to play an important role in the regulation of neutrophil activity. Here, we find that tamoxifen stimulation enhances several pro-inflammatory pathways in human neutrophils, including chemotaxis, phagocytosis and neutrophil extracellular trap (NET) formation. The enhancement of NET production occurs via a ceramide/PKCζ-mediated pathway, and treatment with synthetic ceramide is sufficient to promote NET formation. Pretreatment of human neutrophils with tamoxifen boosts neutrophil bactericidal capacity against a variety of pathogens in vitro and enhances clearance of the leading human pathogen methicillin-resistant Staphylococcus aureus in vivo. Our results suggest that tamoxifen, and the lipid signalling pathways it modulates, merit further exploration as targets for boosting host innate immune function.
Related Papers
- → Ceramide function in the brain: when a slight tilt is enough(2012)248 cited
- → Ceramide synthases as potential targets for therapeutic intervention in human diseases(2013)237 cited
- → The long and the short of ceramides(2018)33 cited
- → Ceramide Transfer Protein and Cancer(2011)14 cited
- → Measurement of Ceramide and Sphingolipid Metabolism in Tumors: Potential Modulation of Chemotherapy(2005)7 cited